The Activation of Proteolysis in the Acrosome Reaction of Guinea-Pig Sperm

Total Page:16

File Type:pdf, Size:1020Kb

The Activation of Proteolysis in the Acrosome Reaction of Guinea-Pig Sperm J. Cell Sci. 32, 153-164 (1978) 153 Printed in Great Britain © Company of Biologists Limited lgyS THE ACTIVATION OF PROTEOLYSIS IN THE ACROSOME REACTION OF GUINEA-PIG SPERM D. P. L. GREEN Physiological Laboratory, Cambridge CBz 3EG, England SUMMARY The divalent metal cation ionophore A23187 rapidly induces a normal acrosome reaction in a population of guinea-pig sperm suspended in calcium medium. In the course of the acrosome reaction, proacrosin, the zymogen precursor of the protease acrosin, is activated. Although the acrosome reaction causes exocytosis of the acrosomal contents, 'soluble' acrosin is not released in significant amounts until well after the sperm population as a whole has undergone an acrosome reaction. This suggests that proacrosin is stored within the acrosome in an insoluble form and that exocytosis of the acrosomal contents in the acrosome reaction is insufficient, by itself, to cause its immediate dissolution. Electron micrographs of sperm undergoing an A23i87-induced acrosome reaction in the presence of the acrosin inhibitors benzamidine, p-amino-benzamidine and phenylmethyl- sulphonyl fluoride show that the acrosome reaction proceeds normally but that dispersal of the acrosomal contents is inhibited. These morphological changes are, for the most part, below the limit of resolution of the light microscope and using light microscopy to assess whether an acrosome reaction has taken place, it can be mistakenly inferred that the reaction itself is inhibited by the acrosin inhibitors. The inhibition of the dispersal of the acrosomal contents by acrosin inhibitors suggests that acrosin activity is important in solubilizing acrosin. These experimental observations, taken with the evidence that the acrosome reaction is a response to an increase in intracellular free calcium, have been taken as the basis of a proposal for the mechanism of proacrosin activation in the acrosome reaction. INTRODUCTION The acrosomes of mammalian sperm contain a number of enzymes. One of these is acrosin, a protease which is broadly similar to trypsin; it hydrolyses the same synthetic substrates (e.g. benzoyl arginine ethyl ester (BAEE), etc.) and it is inhibited by a wide range of synthetic and naturally occurring trypsin inhibitors (e.g. benzamidine, p-aminobenzamidine, soybean trypsin inhibitor, ovomucoid, etc.). Before the acrosome reaction acrosin exists in sperm almost completely as an inactive zymogen precursor, proacrosin (Meizel & Mukerji, 1976). Proacrosin, as far as is known, can only be activated by proteolytic cleavage (cf. trypsinogen, etc.). Activation can be caused by either trypsin or acrosin. There is no direct evidence that proacrosin is activated during the acrosome reaction, although if acrosin is necessary for sperm penetration of the zona it must be. The fate of proacrosin in the acrosome reaction has been examined using the A23i87-induced reaction of guinea-pig sperm (Green, 1978 a). At the same time, the effect of trypsin inhibitors on the acrosome reaction has been studied in view of a report that some inhibitors prevent the acrosome reaction from taking place (Meizel & Lui, 1976). 154 D. P. L. Green METHODS Phenyl methyl sulphonyl fluoride (PMSF), ^-aminobenzamidine, soybean trypsin inhibitor (STI) Type I-S, lima bean trypsin inhibitor (LTI), ovomucoid and benzoyl arginine ethyl ester (BAEE) were purchased from Sigma, and benzamidine from Aldrich. The basic experimental procedures were the same as described previously (Green, 1978a). The time course for the loss of the acrosome induced by A23187 in the presence of trypsin inhibitors was estimated from inspection by light microscopy of sperm fixed at suitable intervals after addition of A23187. The acrosome reaction was induced by addition of 50 /il of the stock solution of A23187 in dimethyl sulphoxide (DMSO) to 5 ml of sperm suspension at 37 °C. Samples (0-5 ml) were pipetted into Karnovsky's fixative in which magnesium and 100 fiM EGTA were substituted for calcium. 500 sperm were examined for each time point. With the exception of PMSF, all inhibitors were dissolved directly in calcium medium. For the experiments with PMSF, 20/tl of a 25 mM stock solution in DMSO were added directly to s ml sperm suspension. In one experiment, sperm were incubated with PMSF in magnesium medium for 0-5 h and then washed 5 times in magnesium medium, 10 ml each time, before resuspension in calcium medium and addition of A23187. Acrosin activity was measured after acid extraction of sperm by following the hydrolysis of BAEE at 256 ran. The acrosome reaction was started with addition of A23187 from a stock solution in DMSO. In a typical experiment, o-s-ml samples were removed from 5 ml of sperm suspension, one sample before and the rest after addition of A23187, and pipetted into 0-5 ml of 20 mM HC1. The acid suspension was centrifuged at 14000 g,v after not less than 15 min and the supernatant assayed for acrosin activity. The assay solution contained 300 mM Tris HC1 buffer, pH 8-o, 150 mM CaCl! and 3 mM BAEE. To 0-9 ml of this solution was first added 0-9 ml of 10 mM KOH followed, after mixing, by 09 ml of acid extract. The change in absorbance at 256 nm was measured at 20 °C in a Zeiss PMQ II spectrophotometer. In one experiment the appearance of soluble acrosin discharged from sperm undergoing an A23i87-induced acrosome reaction was compared with the appearance of acid-extractable acrosin under the same conditions. Sperm in calcium medium were induced to undergo the acrosome reaction by addition of A23187 as before. At suitable time intervals, o-6 ml of sperm suspension was transferred to an Eppendorf tube and spun for 15 s at 14000 g,v. The centrifuge was rapidly stopped and 05 ml of the supernatant pipetted into a test tube containing 0-5 ml of 20 mM HC1. The whole procedure takes about 40-45 s: it was started 15 s before each time point and ended 25-30 s after. The acid solution was assayed as described previously for the acid-extracted acrosin. RESULTS An acrosome reaction is induced in guinea-pig sperm in calcium medium by the divalent cation ionophore A23187 (Green, 1976; Summers et at. 1976; Talbot et al. 1976; Green, 1978 a). The acrosome reaction results in the loss of the acrosome and a substantial change in the shape and size of the head. The time course for the loss of the acrosome is shown in Fig. 3. In the course of the acrosome reaction, the total quantity of acrosin rises (Figs, i, 2). This increase in acrosin reflects the proteolytic activation of proacrosin. Activation is dependent on the concentration of A23187 and external calcium, both in rate and extent (Figs. 1, 2): activation does not occur in magnesium medium after addition of A23187 (Fig. 1) or in magnesium medium containing o-i % Triton X-100. Extraction of sperm with acid removes acrosin and proacrosin (Meizel & Mukerji, 1976) and at the same time dissociates the acrosin inhibitor (Brown, Andani & Hartree, 1975; Schleuning, Hell & Fritz, 1976). The acrosin activity measured there- fore represents total acrosin, not free acrosin. Proteolysis in the acrosome reaction 155 The effect of acrosin inhibitors on the loss of the acrosome during the acrosome reaction is shown in Figs. 3-5. The reversible acrosin inhibitors benzamidine and p-aminobenzamidine and the irreversible acrosin inhibitor PMSF delay but do not prevent the loss of the acrosome (Figs. 3, 5), but the naturally occurring protein acrosin inhibitors, soybean trypsin inhibitor, lima bean trypsin inhibitor and ovomucoid are without effect (Fig. 4). 0-2 r Time, min Figs. 1, 2. Proacrosin activation, induced in guinea-pig sperm in calcium medium by A23187. Fig. 1. Proacrosin activation for a fixed A23187 concentration, 80 fiM, and different external calcium concentrations, inmni: 10, # ; 2, O ; and 0-4, •. Sperm in magnesium show no activation on addition of A23187, •• When sperm in magnesium medium are incubated with PMSF and then extensively washed before resuspension in calcium medium and addition of A23187, the loss of the acrosome takes place normally (Fig. 5). Electron micrographs of sperm undergoing an acrosome reaction in the presence of either p-aminobenzamidine or PMSF fixed 5 min after addition of A23187 (i.e. when Fig. 3 shows the population of sperm to have undergone almost completely an acrosome reaction in the absence of inhibitors) have the appearance shown in Figs. 6 and 7. Both micrographs show head-to-tail sections through a stack of sperm heads. They 156 D.P.L. Green are to be compared with figs. 1 and 4 of the preceding paper (Green, 1978 a). What they both show is that all the sperm have undergone an acrosome reaction, i.e. mem- brane fusion is well advanced, but the acrosomal contents have failed to disperse. As a result, all the sperm, irrespective of the sequence in which they underwent the acrosome reaction have been arrested at the same stage. 0-2 r- 0 5 10 Time, min Fig. 2. Proacrosin activation for a fixed external calcium concentration, 10 mM, and different concentrations of A23187, in/iM; 80, •; 16, •; and 3-2, O- A comparison of the rate of appearance of acid-extractable acrosin with 'soluble' acrosin is shown in Fig. 8. This shows that 'soluble' acrosin does not significantly appear in the supernatant until proacrosin activation is essentially complete. This statement errs on the side of caution because a 15-s spin at 14000 g cannot be con- sidered an adequate test of solubility. It is almost certain, therefore, that release of soluble acrosin is delayed well beyond the period of its formation from proacrosin, if it ever occurs completely at all. Proteolysis in the acrosome reaction 1OOr Time, min Figs. 3—5.
Recommended publications
  • Congenital Diarrheal Disorders: an Updated Diagnostic Approach
    4168 Int. J. Mol. Sci.2012, 13, 4168-4185; doi:10.3390/ijms13044168 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review Congenital Diarrheal Disorders: An Updated Diagnostic Approach Gianluca Terrin 1, Rossella Tomaiuolo 2,3,4, Annalisa Passariello 5, Ausilia Elce 2,3, Felice Amato 2,3, Margherita Di Costanzo 5, Giuseppe Castaldo 2,3 and Roberto Berni Canani 5,6,* 1 Department of Gynecology-Obstetrics and Perinatal Medicine, University of Rome “La Sapienza”, Viale del Policlinico 1, Rome 00161, Italy; E-Mail: [email protected] 2 CEINGE-Advanced Biotechnology, Via Comunale Margherita, Naples 80131, Italy; E-Mails: [email protected] (R.T.); [email protected] (A.E.); [email protected] (F.A.); [email protected] (G.C.) 3 Department of Biochemistry and Biotechnology, University of Naples “Federico II”, Via Pansini 5, Naples 80131, Italy 4 Biotechnology Science, University of Naples “Federico II”, Via De Amicis, Naples 80131, Italy 5 Department of Pediatrics, University of Naples “Federico II”, Via Pansini 5, Naples 80131, Italy; E-Mails: [email protected] (A.P.); [email protected] (M.D.C.) 6 European Laboratory for the Investigation of Food Induced Diseases, University of Naples “Federico II”, Via Pansini 5, Naples 80131, Italy * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel./Fax: +39-0817462680. Received: 18 February 2012; in revised form: 2 March 2012 / Accepted: 19 March 2012 / Published: 29 March 2012 Abstract: Congenital diarrheal disorders (CDDs) are a group of inherited enteropathies with a typical onset early in the life.
    [Show full text]
  • Purification and Identification of a Binding Protein for Pancreatic
    Biochem. J. (2003) 372, 227–233 (Printed in Great Britain) 227 Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A Satoshi TSUZUKI*1,2,Yoshimasa KOKADO*1, Shigeki SATOMI*, Yoshie YAMASAKI*, Hirofumi HIRAYASU*, Toshihiko IWANAGA† and Tohru FUSHIKI* *Laboratory of Nutrition Chemistry, Division of Food Science and Biotechnology, Graduate School of Agriculture, Kyoto University, Kitashirakawa Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan, and †Laboratory of Anatomy, Graduate School of Veterinary Medicine, Hokkaido University, Kita 18-Nishi 9, Kita-ku, Sapporo 060-0818, Japan Pancreatic secretory trypsin inhibitor (PSTI) is a potent trypsin of GzmA-expressing intraepithelial lymphocytes in the rat small inhibitor that is mainly found in pancreatic juice. PSTI has been intestine. We concluded that the PSTI-binding protein isolated shown to bind specifically to a protein, distinct from trypsin, on from the dispersed cells is GzmA that is produced in the the surface of dispersed cells obtained from tissues such as small lymphocytes of the tissue. The rGzmA hydrolysed the N-α- intestine. In the present study, we affinity-purified the binding benzyloxycarbonyl-L-lysine thiobenzyl ester (BLT), and the BLT protein from the 2 % (w/v) Triton X-100-soluble fraction of hydrolysis was inhibited by PSTI. Sulphated glycosaminoglycans, dispersed rat small-intestinal cells using recombinant rat PSTI. such as fucoidan or heparin, showed almost no effect on the Partial N-terminal sequencing of the purified protein gave a inhibition of rGzmA by PSTI, whereas they decreased the inhi- sequence that was identical with the sequence of mouse granzyme bition by antithrombin III.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected]
    University of South Florida Scholar Commons Graduate Theses and Dissertations Graduate School July 2017 Role of Amylase in Ovarian Cancer Mai Mohamed University of South Florida, [email protected] Follow this and additional works at: http://scholarcommons.usf.edu/etd Part of the Pathology Commons Scholar Commons Citation Mohamed, Mai, "Role of Amylase in Ovarian Cancer" (2017). Graduate Theses and Dissertations. http://scholarcommons.usf.edu/etd/6907 This Dissertation is brought to you for free and open access by the Graduate School at Scholar Commons. It has been accepted for inclusion in Graduate Theses and Dissertations by an authorized administrator of Scholar Commons. For more information, please contact [email protected]. Role of Amylase in Ovarian Cancer by Mai Mohamed A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy Department of Pathology and Cell Biology Morsani College of Medicine University of South Florida Major Professor: Patricia Kruk, Ph.D. Paula C. Bickford, Ph.D. Meera Nanjundan, Ph.D. Marzenna Wiranowska, Ph.D. Lauri Wright, Ph.D. Date of Approval: June 29, 2017 Keywords: ovarian cancer, amylase, computational analyses, glycocalyx, cellular invasion Copyright © 2017, Mai Mohamed Dedication This dissertation is dedicated to my parents, Ahmed and Fatma, who have always stressed the importance of education, and, throughout my education, have been my strongest source of encouragement and support. They always believed in me and I am eternally grateful to them. I would also like to thank my brothers, Mohamed and Hussien, and my sister, Mariam. I would also like to thank my husband, Ahmed.
    [Show full text]
  • Rat Prostasin (PRSS8) ELISA Kit
    Product Datasheet Rat Prostasin (PRSS8) ELISA Kit Catalog No: #EK8080 Package Size: #EK8080-1 48T #EK8080-2 96T Orders: [email protected] Support: [email protected] Description Product Name Rat Prostasin (PRSS8) ELISA Kit Brief Description ELISA Kit Applications ELISA Species Reactivity Rat (Rattus norvegicus) Other Names CAP1; PROSTASIN; channel-activating protease 1|prostasin Accession No. Q9ES87 Storage The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. The loss rate was determined by accelerated thermal degradation test. Keep the kit at 37C for 4 and 7 days, and compare O.D.values of the kit kept at 37C with that of at recommended temperature. (referring from China Biological Products Standard, which was calculated by the Arrhenius equation. For ELISA kit, 4 days storage at 37C can be considered as 6 months at 2 - 8C, which means 7 days at 37C equaling 12 months at 2 - 8C). Application Details Detect Range:Request Information Sensitivity:Request Information Sample Type:Serum, Plasma, Other biological fluids Sample Volume: 1-200 µL Assay Time:1-4.5h Detection wavelength:450 nm Product Description Detection Method:SandwichTest principle:This assay employs a two-site sandwich ELISA to quantitate PRSS8 in samples. An antibody specific for PRSS8 has been pre-coated onto a microplate. Standards and samples are pipetted into the wells and anyPRSS8 present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated antibody specific for PRSS8 is added to the wells.
    [Show full text]
  • Isolation and Characterization of Porcine Ott-Proteinase Inhibitor1),2) Leukocyte Elastase-Inhibitor Complexes in Porcine Blood, I
    Geiger, Leysath and Fritz: Porcine otrproteinase inhibitor 637 J. Clin. Chem. Clin. Biochem. Vol. 23, 1985, pp. 637-643 Isolation and Characterization of Porcine ott-Proteinase Inhibitor1),2) Leukocyte Elastase-Inhibitor Complexes in Porcine Blood, I. By R. Geiger, Gisela Leysath and H. Fritz Abteilung für Klinische Chemie und Klinische Biochemie (Leitung: Prof. Dr. H. Fritz) in der Chirurgischen Klinik Innenstadt der Universität München (Received March 18/June 20, 1985) Summary: arProteinase inhibitor was purified from procine blood by ammonium sulphate and Cibachron Blue-Sepharose fractionation, ion exchange chromatography on DEAE-Cellulose, gel filtration on Sephadex G-25, and zinc chelating chromatography. Thus, an inhibitor preparation with a specific activity of 1.62 lU/mgprotein (enzyme: trypsin; Substrate: BzArgNan) was obtained. In sodium dodecyl sulphate gel electroph- oresis one protein band corresponding to a molecular mass of 67.6 kDa was found. On isoelectric focusing 6 protein bands with isoelectric points of 3.80, 3.90, 4.05, 4.20, 4.25 and 4.45 were separated. The amino acid composition was determined. The association rate constants for the Inhibition of various serine proteinases were measured. Isolierung und Charakterisierung des on-Proteinaseinhibitors des Schweins Leukocyten-oLj-Proteinaseinhibitor-Komplexe in Schweineblut, L Zusammenfassung; arProteinaseinhibitor wurde aus Schweineblut mittels Ammoniumsulfatfallung und Frak- tionierung an Cibachron-Blau-Sepharose, lonenaustauschchromatographie an DEAE-Cellulose, Gelfiltration an Sephadex G-25 und Zink-Chelat-Chromatographie isoliert. Die erhaltene Inhibitor-Präparation hatte eine spezifische Aktivität von 1,62 ITJ/mg Protein (Enzym: Trypsin; Substrat: BzArgNan). In der Natriumdodecyl- sulfat-Elektrophorese wurde eine Proteinbande mit einer dazugehörigen Molekülmasse von 67,6 kDa erhalten.
    [Show full text]
  • N-Glycosylation in the Protease Domain of Trypsin-Like Serine Proteases Mediates Calnexin-Assisted Protein Folding
    RESEARCH ARTICLE N-glycosylation in the protease domain of trypsin-like serine proteases mediates calnexin-assisted protein folding Hao Wang1,2, Shuo Li1, Juejin Wang1†, Shenghan Chen1‡, Xue-Long Sun1,2,3,4, Qingyu Wu1,2,5* 1Molecular Cardiology, Cleveland Clinic, Cleveland, United States; 2Department of Chemistry, Cleveland State University, Cleveland, United States; 3Chemical and Biomedical Engineering, Cleveland State University, Cleveland, United States; 4Center for Gene Regulation of Health and Disease, Cleveland State University, Cleveland, United States; 5Cyrus Tang Hematology Center, State Key Laboratory of Radiation Medicine and Prevention, Soochow University, Suzhou, China Abstract Trypsin-like serine proteases are essential in physiological processes. Studies have shown that N-glycans are important for serine protease expression and secretion, but the underlying mechanisms are poorly understood. Here, we report a common mechanism of N-glycosylation in the protease domains of corin, enteropeptidase and prothrombin in calnexin- mediated glycoprotein folding and extracellular expression. This mechanism, which is independent *For correspondence: of calreticulin and operates in a domain-autonomous manner, involves two steps: direct calnexin [email protected] binding to target proteins and subsequent calnexin binding to monoglucosylated N-glycans. Elimination of N-glycosylation sites in the protease domains of corin, enteropeptidase and Present address: †Department prothrombin inhibits corin and enteropeptidase cell surface expression and prothrombin secretion of Physiology, Nanjing Medical in transfected HEK293 cells. Similarly, knocking down calnexin expression in cultured University, Nanjing, China; ‡Human Aging Research cardiomyocytes and hepatocytes reduced corin cell surface expression and prothrombin secretion, Institute, School of Life Sciences, respectively. Our results suggest that this may be a general mechanism in the trypsin-like serine Nanchang University, Nanchang, proteases with N-glycosylation sites in their protease domains.
    [Show full text]
  • Chymotrypsin C (Caldecrin) Promotes Degradation of Human Cationic Trypsin: Identity with Rinderknecht’S Enzyme Y
    Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: Identity with Rinderknecht’s enzyme Y Richa´ rd Szmola and Miklo´ s Sahin-To´ th* Department of Molecular and Cell Biology, Goldman School of Dental Medicine, Boston University, Boston, MA 02118 Communicated by Phillips W. Robbins, Boston Medical Center, Boston, MA, May 2, 2007 (received for review March 19, 2007) Digestive trypsins undergo proteolytic breakdown during their further tryptic sites (10). Autolysis was also proposed to play an transit in the human alimentary tract, which has been assumed to essential role in physiological trypsin degradation in the lower occur through trypsin-mediated cleavages, termed autolysis. Au- intestines. A number of studies in humans have demonstrated tolysis was also postulated to play a protective role against that trypsin becomes inactivated during its intestinal transit, and pancreatitis by eliminating prematurely activated intrapancreatic in the terminal ileum only Ϸ20% of the duodenal trypsin activity trypsin. However, autolysis of human cationic trypsin is very slow is detectable (12–14). On the basis of in vitro experiments, a in vitro, which is inconsistent with the documented intestinal theory was put forth that digestive enzymes are generally resis- trypsin degradation or a putative protective role. Here we report tant to each other and undergo degradation through autolysis that degradation of human cationic trypsin is triggered by chymo- only (10, 15). However, human cationic trypsin was shown to be trypsin C, which selectively cleaves the Leu81-Glu82 peptide bond highly resistant to autolysis, and appreciable autodegradation ؉ within the Ca2 binding loop. Further degradation and inactivation was observed only with extended incubation times in the com- of cationic trypsin is then achieved through tryptic cleavage of the plete absence of Ca2ϩ and salts (16–18).
    [Show full text]
  • Identification and Annotation of Bovine Granzyme Genes Reveals a Novel Granzyme Encoded Within the Trypsin-Like Locus
    Immunogenetics (2018) 70:585–597 https://doi.org/10.1007/s00251-018-1062-6 ORIGINAL ARTICLE Identification and annotation of bovine granzyme genes reveals a novel granzyme encoded within the trypsin-like locus Jie Yang1,2 & Christina Vrettou 1 & Tim Connelley1 & W. Ivan Morrison1 Received: 20 March 2018 /Accepted: 9 May 2018 /Published online: 8 June 2018 # The Author(s) 2018 Abstract Granzymes are a family of serine proteases found in the lytic granules of cytotoxic T lymphocytes and natural killer (NK) cells, which are involved in killing of susceptible target cells. Most information on granzymes and their enzymatic specificities derive from studies in humans and mice. Although granzymes shared by both species show a high level of conservation, the complement of granzyme genes differs between the species. The aim of this study was to identify granzyme genes expressed in cattle, determine their genomic locations and analyse their sequences to predict likely functional specificities. Orthologues of the five granzyme genes found in humans (A, B, H, K and M) were identified, as well a novel gene designated granzyme O, most closely related to granzyme A. An orthologue of granzyme O was found in pigs and a non-function version was detected in the human genome. Use of specific PCRs demonstrated that all of these genes, including granzyme O, are expressed in activated subsets of bovine lymphocytes, with particularly high levels in CD8 T cells. Consistent with findings in humans and mice, the granzyme-encoding genes were located on three distinct genomic loci, which correspond to different proteolytic enzymatic activities, namely trypsin-like, chymotrypsin-like and metase-like.
    [Show full text]
  • Proteolytic Cleavage—Mechanisms, Function
    Review Cite This: Chem. Rev. 2018, 118, 1137−1168 pubs.acs.org/CR Proteolytic CleavageMechanisms, Function, and “Omic” Approaches for a Near-Ubiquitous Posttranslational Modification Theo Klein,†,⊥ Ulrich Eckhard,†,§ Antoine Dufour,†,¶ Nestor Solis,† and Christopher M. Overall*,†,‡ † ‡ Life Sciences Institute, Department of Oral Biological and Medical Sciences, and Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z4, Canada ABSTRACT: Proteases enzymatically hydrolyze peptide bonds in substrate proteins, resulting in a widespread, irreversible posttranslational modification of the protein’s structure and biological function. Often regarded as a mere degradative mechanism in destruction of proteins or turnover in maintaining physiological homeostasis, recent research in the field of degradomics has led to the recognition of two main yet unexpected concepts. First, that targeted, limited proteolytic cleavage events by a wide repertoire of proteases are pivotal regulators of most, if not all, physiological and pathological processes. Second, an unexpected in vivo abundance of stable cleaved proteins revealed pervasive, functionally relevant protein processing in normal and diseased tissuefrom 40 to 70% of proteins also occur in vivo as distinct stable proteoforms with undocumented N- or C- termini, meaning these proteoforms are stable functional cleavage products, most with unknown functional implications. In this Review, we discuss the structural biology aspects and mechanisms
    [Show full text]
  • Kinetics of Inhibition of Sperm L-Acrosin Activity by Suramin
    FEBS 27291 FEBS Letters 544 (2003) 119^122 Kinetics of inhibition of sperm L-acrosin activity by suramin Josephine M. Hermansa;Ã, Dianne S. Hainesa, Peter S. Jamesb, Roy Jonesb aDepartment of Biochemistry and Molecular Biology, School of Pharmacy and Molecular Sciences, James Cook University, Townsville, Qld 4811, Australia bGamete Signalling Laboratory, The Babraham Institute, Cambridge CB2 4AT, UK Received 7 March 2003; revised 28 April 2003; accepted 29 April 2003 First published online 14 May 2003 Edited by Judit Ova¤di binding molecule [7,8], for facilitating dispersal of the acroso- Abstract Sperm L-acrosin activity is inhibited by suramin, a polysulfonated naphthylurea compound with therapeutic poten- mal matrix [9] and as an activator of protease activated re- tial as a combined antifertility agent and microbicide. A kinetic ceptor 2 (PAR2) on the oolemma following zona penetration analysis of enzyme inhibition suggests that three and four mol- [10]. ecules of suramin bind to one molecule of ram and boar In previous experiments we reported that the drug suramin L-acrosins respectively. Surface charge distribution models of inhibits both the amidase activity of L-acrosin and binding of boar L-acrosin based on its crystal structure indicate several spermatozoa to the zona pellucida (ZP) in vitro [11]. Suramin positively charged exosites that represent potential ‘docking’ is a symmetrical hexasulfonated naphthylurea compound (Fig. regions for suramin. It is hypothesised that the spatial arrange- 1) that was originally synthesised as a trypanocidal agent for ment and distance between these exosites determines the ca- treatment of sleeping sickness in East Africa [12]. Lately, it pacity of L-acrosin to bind suramin.
    [Show full text]
  • Proteinase Inhibitor Candidates for Therapy of Enzyme-Inhibitor
    iochemistry of PElmoeary Emphysema Edited by: C. Grassi, J. Travis L. Casali, M. Luisetti Foreword by R. Corsico With 41 figures and 26 tables Springer-Verlag London Berlin Heidelberg New York Paris Tokyo Hong Kong Barcelona Budapest Bi & Gi Publishers - Verona Contents 1. Pulmonary Emphysema: What's Going On 1 C. Grassi, M. Luisetti 2. Elastin and the Lung 13 J. M. Davidson 3. An Introduction to the Endopeptidases 27 A. J. Barrett 4. Lung Proteinases and Emphysema 35 J. G. Bieth 5. Proteinases and Proteinase Inhibitors in the Pathogenesis 47 of Pulmonary Emphysema in Humans R. A. Stockley, D. Burnett 6. Multiple Functions of Neutrophil Proteinases and their 71 Inhibitor Complexes J. Travis, J. Potempa, N. Bangalore, A. Kurdowska 7. Kinetics of the Interaction of Human Leucocyte Elastase with 81 Protein Substrates: Implications for Enzyme Inhibition A. Baici 8. Proteinase Inhibitor Candidates for Therapy of 101 Enzyme-Inhibitor Imbalances H. Fritz, J. Collins, M. Jochum 9. Antileucoprotease (Secretory Leucocyte Proteinase Inhibitor), 113 a Major Proteinase Inhibitor in the Human Lung J. A. Kramps, J. Stolk, A. Rudolphus, J. H. Dijkman 10. Synthetic Mechanism-Based and Transition-State Inhibitors for 123 Human Neutrophil Elastase J. C. Powers, C.-M. Kam, Η. Hon, J. Oleksyszyn, E. F. Meyer Jr. 11. Development and Evaluation of Antiproteases as Drugs for Preventing Emphysema G. L. Snider, P. J. Stone, E. C. Lucey 12. Genetic Control of Human Alpha-l-Antitrypsin and Hepatic Gene Therapy S. L. C Woo, R. N. Sifers, K. Ponder 13. Neutrophils, Neutrophil Elastase and the Fragile Lung: The Pathogenesis and Therapeutic Strategies Relating to Lung Derangement in the Common Hereditary Lung Disorders N.
    [Show full text]